CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sopharma AD is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sopharma AD
rayon Nadezhda, ul. Iliensko Shose No16
Phone: +359 28134523p:+359 28134523 SOFIA, 1220  Bulgaria Ticker: SFASFA
Business Summary
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
5912 Drug stores and proprietary stores
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Ivan O.Donev 38
Deputy Chairman of the Board, Economic Adviser to CEO Vesela L.Stoeva 59 1/1/2000 1/1/2000
Finance Director Boris A.Borisov 1/1/2019
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bulgarska Roza-Sevtopolis AD Kazanlak bul. 23rd Infantry Regiment Shipka 110 Kazalnukk Bulgaria
Sopharma Trading AD ul. Lachezar Stanchev No. 5 SOFIA Bulgaria
Sopharma Properties ADSITS zhk. Kompleks Sofarma Biznes Tauars SOFIA Bulgaria
Momina Krepost AD ul. Magistralna No23 VELIKO TURNOVO Bulgaria

Business Names
Business Name
3JR
Briz
Bulgarska Roza-Sevtopolis AD Kazanlak
6 additional Business Names available in full report.

General Information
Number of Employees: 4,721 (As of 12/31/2023)
Outstanding Shares: 164,771,727 (As of 3/25/2024)
Shareholders: 4,025
Stock Exchange: BUL
Fax Number: +359 28134141


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024